Status:
UNKNOWN
Effect of Oxygen Inhalation on Fatigue After Chemotherapy of Breast Cancer in High Altitude Area
Lead Sponsor:
Jiuda Zhao
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
At present, there are few studies on the side effects of chemotherapy in breast cancer patients at high altitude area, and there are no studies on the relationship between oxygen inhalation and fatigu...
Detailed Description
Fatigue is the most common symptom experienced by patients from cancer diagnosis to the end of life. CRF is different from other types of fatigue. It is severe, persistent and can not be alleviated by...
Eligibility Criteria
Inclusion
- Female breast cancer patients aged ≥ 18 years old;
- Breast cancer was confirmed by histopathological investigation;
- Chemotherapy including neoadjuvant chemotherapy, postoperative adjuvant chemotherapy and palliative chemotherapy for advanced breast cancer;
- Eastern Cooperative Oncology Group（ECOG ）score of physical condition (0-1);
- Voluntarily participate in the clinical trial and sign the informed consent form after informed consent (patients voluntarily accept the test and give informed consent);
- The basic indexes were consistent, and the blood routine and ECG were normal;
- Before chemotherapy, fatigue scale was used to score, and no fatigue symptom was confirmed by CIS and BFI;
Exclusion
- Due to nervous system disease, difficulty in understanding and / or lack of personnel unable to complete the report;
- The patients were treated with radiotherapy at the same time of chemotherapy; 3.There were no other tumors, and brain metastases and pleural effusion were excluded;
- Women diagnosed with untreated anemia and thyroid dysfunction； 5.Heart and lung diseases were excluded; 6.The respiratory system diseases affecting blood oxygen saturation were excluded; 7.Fatigue symptoms were confirmed by cis and BFI.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT04774497
Start Date
March 1 2021
End Date
December 31 2022
Last Update
October 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qinghai University Affiliated Hospital
Xining, Qinghai, China, 810000